TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Verily Life Sciences Stock

Verily Life Sciences Stock

www.verily.com/Healthcare / Medical DevicesFounded: 2015

Verily, founded in 2015, is a life sciences research organization under Alphabet Inc. The company aims to leverage advanced technology to understand health better and to develop tools for early diagnosis and more effective treatments. Targeting healthcare systems and research institutions, Verily is headquartered in South San Francisco, California.

Buy or sell Verily Life Sciences stockLearn more about Verily Life Sciences IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Verily Life Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Verily Life Sciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Verily Life Sciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Verily Life Sciences investors also invested in these private companies

Temasek Holdings
Silver Lake
Teachers' Venture Growth
Alphabet

Team

Management Team

Utpal Koppikar
Chief Financial Officer
Scott Burke
Chief Technology Officer
Preston Simons
Chief Information Officer
Laura Donnell JD
Chief Legal Officer & General Counsel
Alix Hart
Chief Marketing Officer
Kerrie Peraino
Chief People Officer
Vindell Washington MD
Chief Clinical Officer & Director, Health Equity Center of Excellence
Jessica Mega MD
Co-Founder
Stephen Gillett
Chief Executive Officer
Amy Abernethy Ph.D
Chief Medical Officer & President, Product Development
Andrew Trister
Chief Scientific Officer
Lisa Greenbaum
Chief Commercial Officer
Andrew Conrad Ph.D
Co-Founder

Frequently Asked Questions About Verily Life Sciences’ Stock

plusminus
Can you buy Verily Life Sciences’ stock?
Verily Life Sciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Verily Life Sciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Verily Life Sciences’ stock?
Yes, you can sell stock of a private company like Verily Life Sciences. Forge can help you sell your Verily Life Sciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Verily Life Sciences’ stock price?
Verily Life Sciences is a privately held company and therefore does not have a public stock price. However, you may access Verily Life Sciences’ private market stock price with Forge Data.
plusminus
What is Verily Life Sciences’ stock ticker symbol?
Verily Life Sciences does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Verily Life Sciences in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$310.36MM

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Applied Medical Resources

Sector
Healthcare / Medical Devices
 
 

News Highlights

EndPoints News 02/08/2023
Exclusive: Verily welcomes Atara Biotherapeutics veteran as new CFO
Verily, Alphabet’s life sciences outfit, has plucked a new CFO from the ranks of Atara Biotherapeutics, the company announced on Wednesday. Utpal Koppikar joins Verily after a nearly five-year stint as CFO and senior VP at Atara, though his résumé also boasts roles at Gilead and Amgen.

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.